 intraven immun globulin prevent bacteri infect children symptomat human immunodefici viru infect nation institut child health human develop intraven immunoglobulin studi group comment background seriou recurr bacteri infect major caus morbid mortal children human immunodefici viru hiv intraven immun globulin bacteri infect patient primari immunodefici uncontrol studi hiv-infect children multicent studi safeti efficaci children symptomat hiv infect method double-blind trial hiv-infect children mean age month clinic immunolog evid hiv diseas intraven immun globulin mg kilogram bodi weight placebo percent albumin day children group lymphocyt count entri studi clinic classif diseas control median length follow-up month result children group equal liter equal cubic millimet entri treatment intraven immun time free seriou infect infection-fre rate month percent children immun globulin percent placebo addit immun globulin overal reduct number seriou minor bacteri infect rel risk number hospit acut care rel risk benefit children count liter entri group overal trend differ seriou bacteri infect immun globulin placebo infection-fre surviv percent intraven immun globulin percent placebo group estim surviv seriou infect percent intraven immun globulin percent placebo effect treatment mortal group count entri advers reaction percent infus minor conclus symptomat hiv-infect children prophylact use intraven immun globulin safe time free seriou bacteri infect treatment lymphocyt equal liter